Remove Patients Remove Pharmaceutical Remove Physicians Remove Safety
article thumbnail

Patient centricity and the changing pharmaceutical vista

pharmaphorum

Having previously spoken with Dr Mullen three years ago when she was country medical director for the UK & Ireland at GSK – on the topic of patient centricity and embedding that focus within the core of a pharmaceutical company – our recent interview provided some interesting insights into the changing landscape of the industry.

article thumbnail

Leading patient adherence pharmaceutical companies

Pharmaceutical Technology

Failing to adhere to prescribed medication regimens is one of the prime reasons for poor patient health outcomes. Pharmaceutical and healthcare companies are working continuously to improve patient adherence, which also impacts disease control and pharmaceutical industry revenues directly. Patient adherence.

Leads 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Will AI Completely Transform the Patient Experience?

PM360

A similar number of respondents (64%) expressed disappointment with their interaction with physicians, wishing that healthcare providers took more time to understand them. The New England Journal of Medicine runs a weekly diagnostic challenge tasking physicians with correctly identifying a thorny case.

Patients 111
article thumbnail

The Use Of Qr Codes For Patient & Physician Support

Celeritas

A) Aiding Healthcare Professionals (HCPs): Storage of Patient Information: The common method of use of QR codes is in the organization and accessibility of patient records. In essence, patients’ files are all synced to a medical database. They’re ideal for monitoring elderly patients who tend to wander off or sleepwalk.

article thumbnail

Cerner Enviza and FDA partner to develop AI drug safety tools

Pharmaceutical Technology

Oracle company Cerner Enviza and John Snow Labs have collaborated with the US Food and Drug Administration (FDA) for the development of artificial intelligence (AI) tools for drug safety and real-world evidence studies.

Safety 59
article thumbnail

X4 Pharmaceuticals announces positive top-line results for WHIM Syndrome drug

pharmaphorum

X4 Pharmaceuticals has announced positive top-line results from a Phase 3 study of its lead investigational therapy, mavorixafor, in people with warts, hypogammaglobulinemia, infections, and myelokathexis (WHIM) syndrome. Dubbed 4WHIM, the trial was initially designed to enrol 18-28 patients.

article thumbnail

Choosing the Right Sponsorships for Maximum Impact in the Pharmaceutical Industry 

Pharma Marketing Network

Sponsorships can be a powerful tool for pharmaceutical companies to engage with their target audience, build relationships with key stakeholders, and promote their brand in a meaningful way. Provide care to patients? This can help to improve the lives of patients and make a real difference in the world. Fund research?